SELENBP1 expression is associated with poor prognosis in several cancer types, including lung adenocarcinoma, hepatocellular carcinoma, and colorectal carcinogenesis, as well as breast cancer [55,56,57,58]. Here, SELENBP1 is linked to breast carcinoma.